ASX
Lumos Diagnostics Holdings
LDX:ASX•Healthcare
Sensitive ASX Announcement
LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study
Published: 01/09/25, 09:21am (AEST)•3 pages